Nothing Special   »   [go: up one dir, main page]

Guerrero et al., 2016 - Google Patents

TDP-43/FUS in motor neuron disease: Complexity and challenges

Guerrero et al., 2016

View HTML
Document ID
3965320305485121799
Author
Guerrero E
Wang H
Mitra J
Hegde P
Stowell S
Liachko N
Kraemer B
Garruto R
Rao K
Hegde M
Publication year
Publication venue
Progress in neurobiology

External Links

Snippet

Amyotrophic lateral sclerosis (ALS), a common motor neuron disease affecting two per 100,000 people worldwide, encompasses at least five distinct pathological subtypes, including, ALS-SOD1, ALS-C9orf72, ALS-TDP-43, ALS-FUS and Guam-ALS. The etiology of …
Continue reading at www.ncbi.nlm.nih.gov (HTML) (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Hybridisation probes
    • C12Q1/6883—Hybridisation probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids

Similar Documents

Publication Publication Date Title
Guerrero et al. TDP-43/FUS in motor neuron disease: Complexity and challenges
Hampel et al. The β-secretase BACE1 in Alzheimer’s disease
Saez-Atienzar et al. Cellular senescence and Alzheimer disease: the egg and the chicken scenario
Huang et al. A robust TDP-43 knock-in mouse model of ALS
Levi et al. Neurodegeneration with brain iron accumulation: update on pathogenic mechanisms
Bandmann et al. Genetic zebrafish models of neurodegenerative diseases
Wei et al. Environmental enrichment prevents Aβ oligomer-induced synaptic dysfunction through mirna-132 and hdac3 signaling pathways
Zhang et al. Ten-eleven translocation 1 mediated-DNA hydroxymethylation is required for myelination and remyelination in the mouse brain
Li et al. Deficiency of tumor suppressor NDRG2 leads to attention deficit and hyperactive behavior
Son et al. Protection against RAGE-mediated neuronal cell death by sRAGE-secreting human mesenchymal stem cells in 5xFAD transgenic mouse model
Wang et al. Neuronal ApoE4 stimulates C/EBPβ activation, promoting Alzheimer’s disease pathology in a mouse model
Shenouda et al. Mechanisms associated with TDP-43 neurotoxicity in ALS/FTLD
Wang et al. Glutaminase C overexpression in the brain induces learning deficits, synaptic dysfunctions, and neuroinflammation in mice
Zhu et al. Emerging perspectives on DNA double-strand breaks in neurodegenerative diseases
Martin et al. Toxicity in ALS: TDP-43 modifiers and C9orf72
Kumar et al. Amyotrophic lateral sclerosis risk genes and suppressor
Giong et al. Tau accumulation is cleared by the induced expression of VCP via autophagy
Rahman Posttranslational modifications of TDP-43
Zhang et al. TET1-mediated Oligodendrocyte Homeostasis Regulates Myelination and Synaptic Functions
Lim et al. Changes in RBM47 expression based on the timing of melatonin administration and its effects on Nrf2 activity in the hippocampus
Bourefis Novel FUS and CHCHD10 models to investigate pathogenic mechanisms in Amyotrophic Lateral Sclerosis
Kremers Characterising a novel mouse model of amyotrophic lateral sclerosis: a study of senataxin pathology in ALS4
Krupp TDP-43 Pathology in Drosophila Induces Glial Cell-Type-Specific Toxicity that Can Be Ameliorated by Knock-Down of SF2/SRSF1 to Extend Glial Survival
Porter A Neuron-Specific Histone Demethylase Complex Fine Tunes Neurodevelopment
Silva Circadian Regulation of the RNA-Binding Protein Fxr1 and Its Role in Regulating Core Clock Genes